Product Images Tranexamic Acid

Each tablet of this medication contains 650 mg of tranexamic acid and is intended for use by adults. The recommended dosage is two 650-mg tablets taken three times daily during menstruation, not exceeding a total of six tablets in a 24-hour period. This information is in compliance with the United States Pharmacopeia (USP) standards. The medication should be stored at a temperature between 15°C to 30°C (59°F to 86°F) in a light-resistant container as specified by USP guidelines. For more detailed prescribing information, consult the package insert or visit the manufacturer's website.*

Each tablet contains 650 mg of tranexamic acid, USP, with a recommended adult dosage of two tablets taken three times daily during menstruation. The total cost per day is 3.9 cents. It is advised not to take more than 6 tablets within a 24-hour period. The tablets should be stored at a temperature between 15°C to 30°C (59°F to 86°F) and dispensed in a light-resistant container as per USP standards. More information can be found in the package insert. For patient information and the full package insert, visit the website provided. The tablets are distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India.*

Each tablet of this medication contains 650 mg of tranexamic acid, USP. The usual adult dosage is two 650-mg tablets taken three times daily during menstruation, not to exceed 6 tablets in a 24-hour period. This information should be supplemented by consulting the package insert for complete prescribing guidelines. Storage should be at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). The medication needs to be dispensed in a tightly sealed, light-resistant container per USP guidelines. This product is distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India. Visit the provided website for patient information and the package insert.*

Mean Menstrual Blood Loss (mL) comparison between Tranexamic Acid tablets at 3900 mg/day for 3-cycle study and Placebo for the 180 days study. Additionally, comparison for the 6-cycle study between Tranexamic Acid tablets at 3900 mg/day and Placebo. The data is shown for different treatment periods from first to sixth cycle.*